创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

SHI Changyi, ZHAI Hongyang, LIU Shaojie, TANG Weifang. Research Progress of Soluble Guanylate Cyclase Stimulators and Activators[J]. Progress in Pharmaceutical Sciences, 2024, 48(9): 707-715. DOI: 10.20053/j.issn1001-5094.2024.09.006
Citation: SHI Changyi, ZHAI Hongyang, LIU Shaojie, TANG Weifang. Research Progress of Soluble Guanylate Cyclase Stimulators and Activators[J]. Progress in Pharmaceutical Sciences, 2024, 48(9): 707-715. DOI: 10.20053/j.issn1001-5094.2024.09.006

Research Progress of Soluble Guanylate Cyclase Stimulators and Activators

  • Soluble guanylate cyclase (sGC) is a cytosolic heterodimeric protein consisting of α and β subunits with heme groups located in the β subunit (heme binding domain, H-NOX domain). NO stimulates sGC activity by binding to Fe2+ of the heme group, causing cGMP levels to rise. sGC can exist in two different forms, the natural heme-containing form as an endogenous NO receptor and the heme-free form that cannot bind NO. Stimulation of sGC with sGC stimulators or activators is a promising treatment strategy for cardiovascular and cardiac and renal diseases. This article briefly reviews the research progress of sGC stimulators and activators, aiming to provide some reference for the in-depth study of the regulatory mechanism of sGC and the development of sGC stimulators and activators.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return